Category:
Central Nervous System Drugs
CAS NO:
1038915-73-9
Standard:
In-house Standards,

Niraparib is a type of targeted cancer drug called a PARP inhibitor. It is a treatment for some types of ovarian, fallopian tube or primary peritoneal cancers.